While Sagimet Biosciences Inc has overperformed by 4.45%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SGMT rose by 51.33%, with highs and lows ranging from $11.41 to $1.73, whereas the simple moving average jumped by 24.95% in the last 200 days.
On August 11, 2025, Wedbush started tracking Sagimet Biosciences Inc (NASDAQ: SGMT) recommending Outperform. Canaccord Genuity also rated SGMT shares as ‘Buy’, setting a target price of $28 on the company’s shares in an initiating report dated July 24, 2025. Oppenheimer Initiated an Outperform rating on December 06, 2024, and assigned a price target of $30. UBS initiated its ‘Buy’ rating for SGMT, as published in its report on November 12, 2024. Goldman’s report from June 28, 2024 suggests a price prediction of $6 for SGMT shares, giving the stock a ‘Neutral’ rating. H.C. Wainwright also rated the stock as ‘Buy’.
Analysis of Sagimet Biosciences Inc (SGMT)
Sagimet Biosciences Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -37.89% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 17.47, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and SGMT has an average volume of 778.78K. On a monthly basis, the volatility of the stock is set at 6.38%, whereas on a weekly basis, it is put at 6.64%, with a gain of 7.08% over the past seven days. Furthermore, long-term investors anticipate a median target price of $27.86, showing growth from the present price of $6.81, which can serve as yet another indication of whether SGMT is worth investing in or should be passed over.
How Do You Analyze Sagimet Biosciences Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 19.66%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 29.63% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
